AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.240
-0.400 (-8.62%)
At close: Jan 23, 2026, 4:00 PM EST
4.300
+0.060 (1.42%)
After-hours: Jan 23, 2026, 7:58 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.27 billion as of January 23, 2026. Its market cap has increased by 31.01% in one year.
Market Cap
1.27B
Enterprise Value
915.73M
1-Year Change
31.01%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.27B, a decrease of -91.90%. That is a compound annual growth rate of -38.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.27B | 23.98% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.44B |
| uniQure | 1.41B |
| Trevi Therapeutics | 1.40B |
| Taysha Gene Therapies | 1.40B |
| Immatics | 1.36B |
| Pharming Group | 1.36B |
| EyePoint | 1.35B |
| Sana Biotechnology | 1.34B |